BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chong WH, Saha BK, Ananthakrishnan Ramani, Chopra A. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia. Infection 2021;49:591-605. [PMID: 33709380 DOI: 10.1007/s15010-021-01602-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Nas MY, Gabell J, Cianciotto NP. Effectors of the Stenotrophomonas maltophilia Type IV Secretion System Mediate Killing of Clinical Isolates of Pseudomonas aeruginosa. mBio 2021;12:e0150221. [PMID: 34182776 DOI: 10.1128/mBio.01502-21] [Reference Citation Analysis]
2 Burkert FR, Lanser L, Bellmann-Weiler R, Weiss G. Coronavirus Disease 2019: Clinics, Treatment, and Prevention. Front Microbiol 2021;12:761887. [PMID: 34858373 DOI: 10.3389/fmicb.2021.761887] [Reference Citation Analysis]
3 Avdeev S, Rachina S, Belkova Y, Kozlov R, Versporten A, Pauwels I, Goossens H, Bochanova E, Elokhina E, Portnjagina U, Reshetko O, Sychev I, Strelkova D; On behalf of Russian Global-PPS Project Study Group. Antimicrobial Prescribing Patterns in Patients with COVID-19 in Russian Multi-Field Hospitals in 2021: Results of the Global-PPS Project. TropicalMed 2022;7:75. [DOI: 10.3390/tropicalmed7050075] [Reference Citation Analysis]
4 Schwab N, Nienhold R, Henkel M, Baschong A, Graber A, Frank A, Mensah N, Koike J, Hernach C, Sachs M, Daun T, Zsikla V, Willi N, Junt T, Mertz KD. COVID-19 Autopsies Reveal Underreporting of SARS-CoV-2 Infection and Scarcity of Co-infections. Front Med 2022;9:868954. [DOI: 10.3389/fmed.2022.868954] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Langford BJ, So M, Leung V, Raybardhan S, Lo J, Kan T, Leung F, Westwood D, Daneman N, MacFadden DR, Soucy JR. Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression. Clin Microbiol Infect 2021:S1198-743X(21)00636-4. [PMID: 34843962 DOI: 10.1016/j.cmi.2021.11.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
6 Mah-E-Muneer S, Hassan MZ, Biswas MAAJ, Rahman F, Akhtar Z, Das P, Islam MA, Chowdhury F. Use of Antimicrobials among Suspected COVID-19 Patients at Selected Hospitals, Bangladesh: Findings from the First Wave of COVID-19 Pandemic. Antibiotics (Basel) 2021;10:738. [PMID: 34207020 DOI: 10.3390/antibiotics10060738] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Copaja-Corzo C, Hueda-Zavaleta M, Benites-Zapata VA, Rodriguez-Morales AJ. Antibiotic Use and Fatal Outcomes among Critically Ill Patients with COVID-19 in Tacna, Peru. Antibiotics (Basel) 2021;10:959. [PMID: 34439009 DOI: 10.3390/antibiotics10080959] [Reference Citation Analysis]
8 Gabrielli M, Franza L, Esperide A, Gasparrini I, Gasbarrini A, Franceschi F; on behalf of GEMELLI AGAINST COVID 2019. Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy. Vaccines 2022;10:192. [DOI: 10.3390/vaccines10020192] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Oliva A, Ceccarelli G, Borrazzo C, Ridolfi M, D 'Ettorre G, Alessandri F, Ruberto F, Pugliese F, Raponi GM, Russo A, Falletta A, Mastroianni CM, Venditti M. Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission. Infection 2021. [PMID: 34036458 DOI: 10.1007/s15010-021-01624-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Salazar F, Bignell E, Brown GD, Cook PC, Warris A. Pathogenesis of Respiratory Viral and Fungal Coinfections. Clin Microbiol Rev 2021;:e0009421. [PMID: 34788127 DOI: 10.1128/CMR.00094-21] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
11 Saha BK, Chaudhary R, Saha S, Bonnier A, Chong WH, Chenna P. Bronchoscopy During Coronavirus Disease 2019 Pandemic: A Bronchoscopist's Perspective. Crit Care Explor 2021;3:e0522. [PMID: 34514424 DOI: 10.1097/CCE.0000000000000522] [Reference Citation Analysis]
12 Jolobe OMP. A more appropriate use of antibiotics in covid-19 infection. QJM 2021:hcab233. [PMID: 34487187 DOI: 10.1093/qjmed/hcab233] [Reference Citation Analysis]
13 Herrera-Van Oostdam AS, Castañeda-Delgado JE, Oropeza-Valdez JJ, Borrego JC, Monárrez-Espino J, Zheng J, Mandal R, Zhang L, Soto-Guzmán E, Fernández-Ruiz JC, Ochoa-González F, Trejo Medinilla FM, López JA, Wishart DS, Enciso-Moreno JA, López-Hernández Y. Immunometabolic signatures predict risk of progression to sepsis in COVID-19. PLoS One 2021;16:e0256784. [PMID: 34460840 DOI: 10.1371/journal.pone.0256784] [Reference Citation Analysis]
14 Rovina N, Koukaki E, Romanou V, Ampelioti S, Loverdos K, Chantziara V, Koutsoukou A, Dimopoulos G. Fungal Infections in Critically Ill COVID-19 Patients: Inevitabile Malum. J Clin Med 2022;11:2017. [PMID: 35407625 DOI: 10.3390/jcm11072017] [Reference Citation Analysis]
15 Liu HH, Yaron D, Piraino AS, Kapelusznik L. Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors. Ann Clin Microbiol Antimicrob 2021;20:69. [PMID: 34563202 DOI: 10.1186/s12941-021-00472-5] [Reference Citation Analysis]
16 Patel A, Agarwal R, Rudramurthy SM, Shevkani M, Xess I, Sharma R, Savio J, Sethuraman N, Madan S, Shastri P, Thangaraju D, Marak R, Tadepalli K, Savaj P, Sunavala A, Gupta N, Singhal T, Muthu V, Chakrabarti A; MucoCovi Network3. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India. Emerg Infect Dis 2021;27:2349-59. [PMID: 34087089 DOI: 10.3201/eid2709.210934] [Cited by in Crossref: 7] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
17 Chong WH, Neu KP. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review. J Hosp Infect 2021;113:115-29. [PMID: 33891985 DOI: 10.1016/j.jhin.2021.04.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
18 Rizvi A, Saeed MU, Nadeem A, Yaqoob A, Rabaan AA, Bakhrebah MA, Al Mutair A, Alhumaid S, Aljeldah M, Al Shammari BR, Albayat H, Alwashmi ASS, Nainu F, Alhashem YN, Naveed M, Ahmed N. Evaluation of Bi-Lateral Co-Infections and Antibiotic Resistance Rates among COVID-19 Patients in Lahore, Pakistan. Medicina 2022;58:904. [DOI: 10.3390/medicina58070904] [Reference Citation Analysis]
19 Krishna V, Bansal N, Morjaria J, Kaul S. COVID-19-Associated Pulmonary Mucormycosis. JoF 2022;8:711. [DOI: 10.3390/jof8070711] [Reference Citation Analysis]
20 Chong WH, Saha BK, Neu KP. Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis. Infection 2021. [PMID: 34570355 DOI: 10.1007/s15010-021-01701-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 John KJ, Nayar J, Mishra AK, Selvaraj V, Khan MS, Lal A. In-hospital clinical complications of COVID-19: a brief overview. Future Virol 2021. [PMID: 34777553 DOI: 10.2217/fvl-2021-0200] [Reference Citation Analysis]
22 Gutiérrez Rodelo C, Salinas RA, Armenta Jaimearmenta E, Armenta S, Galdámez-martínez A, Castillo-blum SE, Astudillo-de la Vega H, Nirmala Grace A, Aguilar-salinas CA, Gutiérrez Rodelo J, Christie G, Alsanie WF, Santana G, Thakur VK, Dutt A. Zinc associated nanomaterials and their intervention in emerging respiratory viruses: Journey to the field of biomedicine and biomaterials. Coordination Chemistry Reviews 2022;457:214402. [DOI: 10.1016/j.ccr.2021.214402] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
23 Zhao XL, Qi Z, Huang H, Tu J, Song XJ, Qi KZ, Shao Y. Coexistence of antibiotic resistance genes, fecal bacteria, and potential pathogens in anthropogenically impacted water. Environ Sci Pollut Res Int 2022;29:46977-90. [PMID: 35175529 DOI: 10.1007/s11356-022-19175-1] [Reference Citation Analysis]
24 Mas-Ubillus G, Ortiz PJ, Huaringa-Marcelo J, Sarzo-Miranda P, Muñoz-Aguirre P, Diaz-Ramos A, Arribasplata-Purizaca K, Mendoza D, Rojas-Poma J, Marcelo-Ruiz C, Ayala-Diaz P, Hidalgo-Arroyo E, Tupia-Cespedes L. High mortality among hospitalized adult patients with COVID-19 pneumonia in Peru: A single centre retrospective cohort study. PLoS One 2022;17:e0265089. [PMID: 35259196 DOI: 10.1371/journal.pone.0265089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Caffrey AR, Appaneal HJ, Liao JX, Piehl EC, Lopes V, Puzniak LA. Treatment Heterogeneity in Pseudomonas aeruginosa Pneumonia. Antibiotics 2022;11:1033. [DOI: 10.3390/antibiotics11081033] [Reference Citation Analysis]
26 Cihakova D, Streiff MB, Menez SP, Chen TK, Gilotra NA, Michos ED, Marr KA, Karaba AH, Robinson ML, Blair PW, Dioverti MV, Post WS, Cox AL, R Antar AA. High-value laboratory testing for hospitalized COVID-19 patients: a review. Future Virol 2021. [PMID: 34567235 DOI: 10.2217/fvl-2020-0316] [Reference Citation Analysis]
27 Mylvaganam RJ, Bailey JI, Sznajder JI, Sala MA; Northwestern Comprehensive COVID Center Consortium. Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection. Eur Respir Rev 2021;30:210194. [PMID: 34911696 DOI: 10.1183/16000617.0194-2021] [Reference Citation Analysis]
28 Chong WH, Saha BK, Chopra A. Narrative review of the relationship between COVID-19 and PJP: does it represent coinfection or colonization? Infection 2021. [PMID: 34059997 DOI: 10.1007/s15010-021-01630-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]